Sort
30,917 grants matching “tumor microenvironment”
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
$411,278Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2017 · CA
Leukocyte Biomarkers for Predicting Human Breast Cancer Outcomes
$411,273Lisa M Coussens · Oregon Health & Science University · U54 · FY2012 · CA
Targeting Nucleotide Excision Repair Deficiency to Improve Bladder Sparing Treatment for Muscle Invasive Bladder Cancer
$411,213Kent W Mouw · Dana-Farber Cancer Inst · R01 · FY2024 · CA
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$411,170John H Sampson · Duke University · R01 · FY2013 · NS
Project 1: Discovery of novel tumor-tissue based predictors of lethal colorectal cancer by race/ethnicity
$411,154Christopher I Li · Fred Hutchinson Cancer Center · P20 · FY2022 · CA
Functional Determinants of Metastatic Dormancy
$411,127Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Informatics for Integrative Brain Tumor Whole Slide Analysis
$411,017Joel H Saltz · State University New York Stony Brook · R01 · FY2014 · LM
Collaborative Innate-Adaptive Immune Regulation of Tumor Progression
$410,978Matthew F Krummel · University Of California, San Francisco · U01 · FY2012 · CA
Developing a Translation Pipeline for VHL Mutant Malignancies
$410,974David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2020 · CA
TLR5 signaling as a conserved mechanism of impaired anti-tumor immunity
$410,973Melanie R Rutkowski · University Of Virginia · R01 · FY2025 · CA
Mechanisms of immunomodulatory and anti-tumor actions of Polysaccharide Krestin
$410,922Mary L. Disis · University Of Washington · R01 · FY2007 · AT
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
$410,899Margaret A Shipp · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
$410,877Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
$410,877Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
MiRNAs in hepatocellular carcinoma development and treatment
$410,875Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
MiRNAs in hepatocellular carcinoma development and treatment
$410,875Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
MiRNAs in hepatocellular carcinoma development and treatment
$410,875Wendong Huang · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Deep exploration of drivers, evolution, and microenvironment toward discovering principal themes in cancer
$410,850Li Ding · Washington University · U24 · FY2021 · CA
Studies on the effects of a novel intermittent therapy on intratumoral clonal architecture and resistance
$410,835Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Lipid programs in melanocyte transformation
$410,835Richard Mark White · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Investigating Microenvironmental Interactions in Leptomeningeal Metastasis
$410,835Adrienne A. Boire · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Investigating Microenvironmental Interactions in Leptomeningeal Metastasis
$410,835Adrienne A. Boire · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
$410,835Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
$410,835Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Investigating Microenvironmental Interactions in Leptomeningeal Metastasis
$410,835Adrienne A. Boire · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA